Central Northern Adelaide Renal and Transplantation Services (CNARTS), Royal Adelaide Hospital, Port Road, Adelaide, Australia.
Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia.
J Nephrol. 2022 Jul;35(6):1689-1698. doi: 10.1007/s40620-022-01288-y. Epub 2022 Mar 28.
Evidence surrounding vascular access options for commencing dialysis in pregnancy complicated by chronic kidney disease (CKD) is limited. Creation of new arteriovenous fistulas (AVFs) in pregnant women is rare.
Retrospective cohort study of approaches to vascular access in pregnancy in centres in Australia, the United Kingdom (UK) and Canada (2002-2018).
Twenty-three women with advanced CKD commenced dialysis in pregnancy (n = 20) or planned to commence (n = 3). Access at dialysis start was a tunnelled catheter (n = 13), temporary catheter (n = 1), AVF created pre-conception but used in pregnancy (n = 3) and AVF created during pregnancy (n = 3). No women commencing dialysis with an AVF required a catheter. No differences in perinatal outcomes were observed comparing AVFs and catheters at dialysis commencement. No AVFs were created in pregnancy in Canadian women. From Australia and the UK, 10 women had a new AVF created in pregnancy, at median gestation 14.5 weeks (IQR 12.5, 20.75). Four women still needed a catheter for dialysis initiation and 3 eventually used the new AVF. Six AVFs were successfully used in pregnancy at median gestation 24 weeks (IQR 22.5, 28.5), 2 were successfully created but not used and 2 had primary failure. No catheter-associated complications were identified except one episode of catheter-related sepsis.
Catheter-related complications were minimal. In selected women, with sufficient pre-planning, an AVF can be created and successfully used during pregnancy to minimise catheter use if preferred. Pre-conception counselling in advanced CKD should include discussing vascular access options reflecting local expertise and patient preferences.
关于在患有慢性肾脏病(CKD)的孕妇中开始透析时血管通路选择的证据有限。在孕妇中创建新的动静脉瘘(AVF)很少见。
对澳大利亚、英国和加拿大(2002-2018 年)中心的孕妇血管通路方法进行回顾性队列研究。
23 名患有晚期 CKD 的女性在妊娠中开始透析(n=20)或计划开始透析(n=3)。开始透析时的通路是经皮隧道导管(n=13)、临时导管(n=1)、在妊娠前创建但在妊娠中使用的 AVF(n=3)和在妊娠中创建的 AVF(n=3)。没有使用 AVF 开始透析的女性需要使用导管。在开始透析时使用 AVF 和导管,围产期结局没有差异。加拿大女性在妊娠期间没有创建 AVF。来自澳大利亚和英国的 10 名女性在妊娠期间创建了新的 AVF,中位孕龄为 14.5 周(IQR 12.5,20.75)。4 名女性仍需要导管开始透析,3 名女性最终使用新的 AVF。6 个 AVF 在中位孕龄 24 周(IQR 22.5,28.5)期间成功用于妊娠,2 个 AVF成功创建但未使用,2 个 AVF 原发性失败。除了 1 例导管相关性败血症外,未发现与导管相关的并发症。
导管相关并发症很少。在有足够的预先计划的情况下,对于某些女性,可以在妊娠期间创建和成功使用 AVF,以尽量减少导管的使用(如果首选)。在晚期 CKD 患者中进行妊娠前咨询时,应包括讨论反映当地专业知识和患者偏好的血管通路选择。